PIPAC (Phenomenology & Mind)

ISBN 13: 9783110345940

PIPAC (Phenomenology & Mind)

0 valoración promedio
( 0 valoraciones por Goodreads )
 
9783110345940: PIPAC (Phenomenology & Mind)

Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer.
However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration.
A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step, a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system.
Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low.
In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations.

"Sinopsis" puede pertenecer a otra edición de este libro.

About the Author:

Arianna Betti, Universiteit van Amsterdam, Niederlande; Venanzio Raspa, Amsterdam, Niederlande.

"Sobre este título" puede pertenecer a otra edición de este libro.

Los mejores resultados en AbeBooks

1.

Reymond, Marc A.
Editorial: De Gruyter 1
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Tapa dura Cantidad: 1
Librería
Powell's Books
(Portland, OR, Estados Unidos de America)
Valoración
[?]

Descripción De Gruyter 1. Hardcover. Estado de conservación: New. HARDCOVER Legendary independent bookstore online since 1994. Reliable customer service and no-hassle return policy. Humanities>Philosophy>Logic. Book: NEW, New. Bookseller Inventory # 64978311034594000. Nº de ref. de la librería 64978311034594000

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 111,95
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,83
A Estados Unidos de America
Destinos, gastos y plazos de envío

2.

Marc A. Reymond, Wiebke Solass
Editorial: Walter de Gruyter & Co 2014-09-15 (2014)
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Tapa dura Cantidad: 5
Librería
Chiron Media
(Wallingford, Reino Unido)
Valoración
[?]

Descripción Walter de Gruyter & Co 2014-09-15, 2014. Hardcover. Estado de conservación: New. Nº de ref. de la librería NU-LBR-01393498

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 130,27
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,36
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

3.

ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Cantidad: 5
Librería
GreatBookPrices
(Columbia, MD, Estados Unidos de America)
Valoración
[?]

Descripción Estado de conservación: New. Nº de ref. de la librería 23425468-n

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 135,31
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 2,25
A Estados Unidos de America
Destinos, gastos y plazos de envío

4.

Editorial: De Gruyter (2014)
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Tapa dura Primera edición Cantidad: 1
Librería
Irish Booksellers
(Rumford, ME, Estados Unidos de America)
Valoración
[?]

Descripción De Gruyter, 2014. Hardcover. Estado de conservación: New. book. Nº de ref. de la librería M3110345943

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 146,22
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Marc A. Reymond (editor), Wiebke Solass (editor)
Editorial: De Gruyter 2014-09-15, Berlin (2014)
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Tapa dura Cantidad: 1
Librería
Blackwell's
(Oxford, OX, Reino Unido)
Valoración
[?]

Descripción De Gruyter 2014-09-15, Berlin, 2014. hardback. Estado de conservación: New. Nº de ref. de la librería 9783110345940

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 139,95
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,75
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

6.

Marc A. Reymond
Editorial: Walter De Gmbh Gruyter Sep 2014 (2014)
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Cantidad: 1
Librería
Rheinberg-Buch
(Bergisch Gladbach, Alemania)
Valoración
[?]

Descripción Walter De Gmbh Gruyter Sep 2014, 2014. Buch. Estado de conservación: Neu. Neuware - Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer.However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration. A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step,a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system. Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low. In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations. 232 pp. Englisch. Nº de ref. de la librería 9783110345940

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 139,95
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 17,13
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

7.

Marc A. Reymond
Editorial: Walter De Gmbh Gruyter Sep 2014 (2014)
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Cantidad: 1
Librería
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Alemania)
Valoración
[?]

Descripción Walter De Gmbh Gruyter Sep 2014, 2014. Buch. Estado de conservación: Neu. Neuware - Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer.However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration. A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step,a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system. Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low. In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations. 232 pp. Englisch. Nº de ref. de la librería 9783110345940

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 139,95
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 17,13
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

8.

Editorial: De Gruyter (2014)
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Tapa dura Primera edición Cantidad: 1
Librería
Valoración
[?]

Descripción De Gruyter, 2014. Estado de conservación: New. Nº de ref. de la librería L9783110345940

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 159,96
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 2,99
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

9.

Editorial: De Gruyter, Germany (2014)
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Tapa dura Cantidad: 6
Librería
The Book Depository EURO
(London, Reino Unido)
Valoración
[?]

Descripción De Gruyter, Germany, 2014. Hardback. Estado de conservación: New. Language: English . Brand New Book. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel approach for treating peritoneal carcinomatosis. First encouraging results have been obtained in human patients. Nº de ref. de la librería LIB9783110345940

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 209,92
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,38
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

10.

Kazimierz Twardowski
ISBN 10: 3110345943 ISBN 13: 9783110345940
Nuevos Tapa dura Cantidad: 1
Librería
AussieBookSeller
(SILVERWATER, NSW, Australia)
Valoración
[?]

Descripción Hardcover. Estado de conservación: New. Hardcover. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. 252 pages. 0.617. Nº de ref. de la librería 9783110345940

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 225,00
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 31,54
De Australia a Estados Unidos de America
Destinos, gastos y plazos de envío

Existen otras copia(s) de este libro

Ver todos los resultados de su búsqueda